Pin it

IP and Hallucinogens – is it possible?

The blog provides an overview of the overlapping IP and ethical issues on the use of hallucinating substances such as LSD, psilocybin, MDMA etc. for psychedelics therapies. Mental illness is not restricted to any country and can affect anyone’s regula ...

Read More
Pin it

Is the EU Falsified Medicine Directive efficient to curb counterfeits?

The article analyses the 2019 amendment of the EU Falsified Medicine Directive that introduced Article 54(a) and Article 4. The provisions are incorporated to protect the interest of patients. They are closely associated with the European Union Trade ...

Read More
Linkedin
×
Cart